Home / Health / Cancer Fight: New Therapies Promise Longer Lives
Cancer Fight: New Therapies Promise Longer Lives
30 Mar
Summary
- Cancer survival in the UK has doubled since the 1970s.
- New therapies include gene editing and immunotherapies.
- Research focuses on challenging cancer's ability to adapt.
Cancer survival rates in the UK have seen a remarkable increase, with a 10-year survival rate now at 50%, up from 25% in the early 1970s. This advancement is largely attributed to significant contributions from Cancer Research UK, a major funder of scientific breakthroughs.
Cutting-edge technologies such as immunotherapies, targeted treatments, advanced genetic sequencing, gene editing, liquid biopsies, and AI are revolutionizing cancer care. Researchers are exploring novel approaches, like the REWIRE-CAN initiative, which aims to stress cancer cells by overloading their growth signals, and NexTGen, developing CAR-T cell therapies for solid tumors.
Further innovations include gene therapy for aggressive brain tumors and microbiome-based treatments to enhance immunotherapy efficacy. These ongoing efforts, supported by initiatives like Cancer Grand Challenges, are paving the way for more effective treatments and improved patient outcomes, offering renewed hope for a future with longer, better lives for those affected by cancer.
